On the other hand, the HPA dataset provided an immunohistochemical analysis of TNFAIP6, IFRD1, IFITM2, IFNGR1, IRF6, and NFIL3 protein expression, which was carried out using peroxidase-conjugated antibodies such as CAB032719 for TNFAIP6, HPA024122 for IFRD1, HPA004337 for IFITM2, and HPA063871 and CAB025889 for IFNGR1 (normal and tumor tissue, respectively), HPA063121 for IRF6 and HPA003261 for NFIL3 and employing specimens derived from both normal breast tissue and invasive breast carcinoma cases. This evidence concerns the gene IFITM2 and invasive breast carcinoma.